Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 180

1.

Microarray analysis of B-cell lymphoma cell lines with the t(14;18).

Robetorye RS, Bohling SD, Morgan JW, Fillmore GC, Lim MS, Elenitoba-Johnson KS.

J Mol Diagn. 2002 Aug;4(3):123-36.

PMID:
12169673
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Immunohistochemical expression of CD10 and t(14;18) chromosomal translocation may be indicators of follicle centre cell origin in nodal diffuse large B-cell lymphoma.

McCluggage WG, Catherwood M, Alexander HD, McBride HA, Smith ME, Morris TC.

Histopathology. 2002 Nov;41(5):414-20.

PMID:
12405909
[PubMed - indexed for MEDLINE]
3.

Gene expression profile of serial samples of transformed B-cell lymphomas.

de Vos S, Hofmann WK, Grogan TM, Krug U, Schrage M, Miller TP, Braun JG, Wachsman W, Koeffler HP, Said JW.

Lab Invest. 2003 Feb;83(2):271-85.

PMID:
12594241
[PubMed - indexed for MEDLINE]
4.

Absence of the t(14;18) chromosomal translocation in primary cutaneous B-cell lymphoma.

Child FJ, Russell-Jones R, Woolford AJ, Calonje E, Photiou A, Orchard G, Whittaker SJ.

Br J Dermatol. 2001 Apr;144(4):735-44.

PMID:
11298531
[PubMed - indexed for MEDLINE]
5.

bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas.

Cerroni L, Volkenandt M, Rieger E, Soyer HP, Kerl H.

J Invest Dermatol. 1994 Feb;102(2):231-5.

PMID:
8106752
[PubMed - indexed for MEDLINE]
6.

Bcl-6 and Bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: correlation with 3q27 and 18q21 chromosomal abnormalities.

Skinnider BF, Horsman DE, Dupuis B, Gascoyne RD.

Hum Pathol. 1999 Jul;30(7):803-8.

PMID:
10414499
[PubMed - indexed for MEDLINE]
7.

BCL2 and JUNB abnormalities in primary cutaneous lymphomas.

Mao X, Orchard G, Lillington DM, Child FJ, Vonderheid EC, Nowell PC, Bagot M, Bensussan A, Russell-Jones R, Young BD, Whittaker SJ.

Br J Dermatol. 2004 Sep;151(3):546-56.

PMID:
15377339
[PubMed - indexed for MEDLINE]
8.

Frequent incidence of somatic mutations in translocated BCL2 oncogenes of non-Hodgkin's lymphomas.

Tanaka S, Louie DC, Kant JA, Reed JC.

Blood. 1992 Jan 1;79(1):229-37.

PMID:
1339299
[PubMed - indexed for MEDLINE]
Free Article
9.

Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3.

Schaefer KL, Brachwitz K, Wai DH, Braun Y, Diallo R, Korsching E, Eisenacher M, Voss R, Van Valen F, Baer C, Selle B, Spahn L, Liao SK, Lee KA, Hogendoorn PC, Reifenberger G, Gabbert HE, Poremba C.

Cancer Res. 2004 May 15;64(10):3395-405.

PMID:
15150091
[PubMed - indexed for MEDLINE]
Free Article
10.
11.

Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.

Tracey L, Pérez-Rosado A, Artiga MJ, Camacho FI, Rodríguez A, Martínez N, Ruiz-Ballesteros E, Mollejo M, Martinez B, Cuadros M, Garcia JF, Lawler M, Piris MA.

J Pathol. 2005 Jun;206(2):123-34.

PMID:
15880597
[PubMed - indexed for MEDLINE]
12.

CD10 antigen expression correlates with the t(14;18)(q32;q21) major breakpoint region in diffuse large B-cell lymphoma.

Fang JM, Finn WG, Hussong JW, Goolsby CL, Cubbon AR, Variakojis D.

Mod Pathol. 1999 Mar;12(3):295-300.

PMID:
10102615
[PubMed - indexed for MEDLINE]
13.

Analysis of LAZ3 (BCL-6) status in B-cell non-Hodgkin's lymphomas: results of rearrangement and gene expression studies and a mutational analysis of coding region sequences.

Otsuki T, Yano T, Clark HM, Bastard C, Kerckaert JP, Jaffe ES, Raffeld M.

Blood. 1995 May 15;85(10):2877-84.

PMID:
7742550
[PubMed - indexed for MEDLINE]
Free Article
14.

Microarray analysis of gene-expression profiles in diffuse large B-cell lymphoma: identification of genes related to disease progression.

Nishiu M, Yanagawa R, Nakatsuka S, Yao M, Tsunoda T, Nakamura Y, Aozasa K.

Jpn J Cancer Res. 2002 Aug;93(8):894-901.

PMID:
12716467
[PubMed - indexed for MEDLINE]
15.

Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures.

Mahadevan D, Spier C, Della Croce K, Miller S, George B, Riley C, Warner S, Grogan TM, Miller TP.

Mol Cancer Ther. 2005 Dec;4(12):1867-79.

PMID:
16373702
[PubMed - indexed for MEDLINE]
Free Article
16.

Detection of chimaeric transcripts of the immunoglobulin heavy chain and BCL6 genes by reverse-transcriptase polymerase chain reaction in B-cell non-Hodgkin's lymphomas.

Kawamata N, Nakamura Y, Miki T, Sato E, Isobe Y, Furusawa S, Hirosawa S, Oshimi K.

Br J Haematol. 1998 Mar;100(3):484-9.

PMID:
9504630
[PubMed - indexed for MEDLINE]
17.
18.

FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.

Takahashi H, Feuerhake F, Kutok JL, Monti S, Dal Cin P, Neuberg D, Aster JC, Shipp MA.

Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3265-71.

PMID:
16740746
[PubMed - indexed for MEDLINE]
Free Article
19.

Expression of the PAX5/BSAP transcription factor in haematological tumour cells and further molecular characterization of the t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma.

Hamada T, Yonetani N, Ueda C, Maesako Y, Akasaka H, Akasaka T, Ohno H, Kawakami K, Amakawa R, Okuma M.

Br J Haematol. 1998 Aug;102(3):691-700.

PMID:
9722295
[PubMed - indexed for MEDLINE]
20.

Rituximab induces different but overlapping sets of genes in human B-lymphoma cell lines.

Cittera E, Onofri C, D'Apolito M, Cartron G, Cazzaniga G, Zelante L, Paolucci P, Biondi A, Introna M, Golay J.

Cancer Immunol Immunother. 2005 Mar;54(3):273-86. Epub 2004 Sep 23.

PMID:
15449038
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk